Philadelphia Pharmaceuticals Company (ASE:PHIL)

Jordan flag Jordan · Delayed Price · Currency is JOD
1.500
-0.010 (-0.66%)
At close: Apr 9, 2026
8.70%
Market Cap 11.25M
Revenue (ttm) 9.17M
Net Income (ttm) 1.01M
Shares Out 7.50M
EPS (ttm) 0.13
PE Ratio 11.19
Forward PE n/a
Dividend 0.07 (4.67%)
Ex-Dividend Date Mar 30, 2026
Volume 1,000
Average Volume 402
Open 1.510
Previous Close 1.510
Day's Range 1.500 - 1.510
52-Week Range 1.360 - 1.700
Beta -0.04
RSI 44.90
Earnings Date Apr 23, 2026

About ASE:PHIL

Philadelphia Pharmaceuticals Company develops, manufactures, and markets human pharmaceutical products, cosmetics, and medical devices of various therapeutic categories in Jordan. The company provides products for skin related disorders, including anti-lice and scabicides preparations, antiseptics and disinfectants, bleaching and hyperpigmentation disorders preparations, emollients and protectives, keratolytics/topical psoriasis treatment preparations, and skin healing agents, as well as agents for dermatitis; and topical acne preparation, anti... [Read more]

Industry Pharmaceutical Preparations
Founded 1993
Employees 129
Stock Exchange Amman Stock Exchange
Ticker Symbol PHIL
Full Company Profile

Financial Performance

In 2025, ASE:PHIL's revenue was 9.17 million, an increase of 4.64% compared to the previous year's 8.76 million. Earnings were 1.01 million, an increase of 22.35%.

Financial Statements

News

There is no news available yet.